A new CAR-T cell therapy for treating aggressive brain and spinal cord tumors in young people has shown promising results in a recent trial conducted by Stanford University. Out of 11 participants, nine experienced significant clinical improvements, with one achieving a complete response. While the results are encouraging, researchers emphasize the need for further optimization and understanding of the treatment's effectiveness across different patients. Teljes cikk (Euronews.com)